Publications by authors named "Philippe Beauverger"

Claim this Profile
T
The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy.
Jean-Baptiste Reisqs, Adrien Moreau, Azzouz Charrabi, Yvonne Sleiman, Albano C Meli, Philippe Beauverger

Clin Transl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR340835, a Novel Selective Na/Ca Exchanger Inhibitor, Improves Cardiac Function and Restores Sympathovagal Balance in Heart Failure.
Michel Pelat, Fabrice Barbe, Cyril Daveu, Laetitia Ly-Nguyen, Thomas Lartigue, Philippe Beauverger

J Pharmacol Exp Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oral Ca/calmodulin-dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure.
Julian Mustroph, Marzena Drzymalski, Maria Baier, Steffen Pabel, Alexander Biedermann, Philippe Beauverger

ESC Heart Fail· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A label-free impedance assay in endothelial cells differentiates the activation and desensitization properties of clinical S1P agonists.
Patrick Grailhe, Asma Boutarfa-Madec, Philippe Beauverger, Philip Janiak, Ashfaq A Parkar

FEBS Open Bio· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated Comorbidities.
Marie-Laure Ozoux, Véronique Briand, Michel Pelat, Fabrice Barbe, Paul Schaeffer, Philippe Beauverger

J Pharmacol Exp Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of sarcolipin expression and altered calcium cycling in cardiomyopathy.
Blanca Morales Rodriguez, Alejandro Domínguez-Rodríguez, Jean-Pierre Benitah, Florence Lefebvre, Thibaut Marais, Philippe Beauverger

Biochem Biophys Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy.
Philippe Beauverger, Marie-Laure Ozoux, Guillaume Bégis, Valérie Glénat, Véronique Briand

Cardiovasc Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CaMKII as a pathological mediator of ER stress, oxidative stress, and mitochondrial dysfunction in a murine model of nephronophthisis.
Christina Bracken, Philippe Beauverger, Olivier Duclos, Ryan J Russo, Kelly A Rogers

Am J Physiol Renal Physiol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay.
Philippe Beauverger, Marianne Rodriguez, Jean-Paul Nicolas, Valérie Audinot, Véronique Lamamy

Cell Signal· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.
Marianne Rodriguez, Valérie Audinot, Sandra Dromaint, Christelle Macia, Véronique Lamamy, Philippe Beauverger

Biochem J· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand modulation of [35S]GTPgammaS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptors.
Valérie Audinot, Nelly Fabry, Jean-Paul Nicolas, Philippe Beauverger, Adrian Newman-Tancredi

Cell Signal· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SVK14 cells express an MCH binding site different from the MCH1 or MCH2 receptor.
Valérie Audinot, Chantal Lahaye, Thomas Suply, Carole Rovère-Jovène, Marianne Rodriguez, Philippe Beauverger

Biochem Biophys Res Commun· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanin-concentrating hormone and its receptors: state of the art.
Jean A Boutin, Thomas Suply, Valérie Audinot, Marianne Rodriguez, Philippe Beauverger

Can J Physiol Pharmacol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis